Autopsy report · NCT03862248
Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
Cause of deathOther
“Feasibility of the clinical trial could not be confirmed at the different sites.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- Institute of Tropical Medicine, Belgium
- Sponsor type
- University, hospital or other
- Conditions
- Tuberculosis, Pulmonary
- Interventions
- 6EH³RZ; 6EHR³Z; 6EHRZLfx
- Participants
- 0
- Sites
- 1
- Countries
- Bangladesh
Trials that died the same way
- Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
“FDA request as study could not serve as the confirmatory trial.” - The Occurrence of Atrial Fibrillation After Totally Endoscopic Cardiac Surgery
“After the passing of the principal investigator, the clinical trial could not be continued.” - Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)
“This project was not a clinical trial requiring registration” - Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
“While the clinical need for and the scientific merit remain valid, this regulated drug trial was not feasible logistically due to limited funds.” - DASH - Decision Making in Adolescent Sexual Health
“This research was not conducted at UNM \& not Applicable Clinical Trial.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.